Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.

  • Read more about Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.

Outreach strategies for Southeast Asian communities: experience, practice, and suggestions for approaching Southeast Asian immigrant and refugee communities to provide thalassemia education and trait testing.

  • Read more about Outreach strategies for Southeast Asian communities: experience, practice, and suggestions for approaching Southeast Asian immigrant and refugee communities to provide thalassemia education and trait testing.

Changing outcome of homozygous alpha-thalassemia: cautious optimism.

  • Read more about Changing outcome of homozygous alpha-thalassemia: cautious optimism.

Collection of sibling donor cord blood for children with thalassemia.

  • Read more about Collection of sibling donor cord blood for children with thalassemia.

Bone marrow transplantation for beta-thalassemia: the University of California San Francisco experience.

  • Read more about Bone marrow transplantation for beta-thalassemia: the University of California San Francisco experience.

Is adjuvant therapy ever warranted in localized neuroblastoma.

  • Read more about Is adjuvant therapy ever warranted in localized neuroblastoma.

Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease.

  • Read more about Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease.

Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease.

  • Read more about Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease.

Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.

  • Read more about Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.

Bone marrow transplantation for sickle cell disease: where do we go from here?

  • Read more about Bone marrow transplantation for sickle cell disease: where do we go from here?

Pagination

  • Previous page ‹‹
  • Page 5
  • Next page ››
Subscribe to Journal of pediatric hematology/oncology

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List